| Literature DB >> 24865397 |
Chi-Ting Chiang1, Ie-Bin Lian2, Ying-Fang Chang3, Tsun-Kuo Chang4.
Abstract
Some specific types of cancer still pose a severe threat to the health of Taiwanese women. This study focuses on determining the geographical locations of hot spots and causal factors related to the major categories of cancers in Taiwanese women. Cancer mortality data from 1972 to 2001 of 346 townships in Taiwan were obtained from the Atlas of Cancer Mortality. Principal component analysis was conducted to determine the primary categories of female cancers. The spatial patterns of hot spots and cold spots for each major cancer category were identified using the local indicator of spatial association. Finally, the regional differences between the hot spots and cold spots were compared to confirm the possible factors causing cancer throughout Taiwan. A total of 21 cancer types in women were divided into seven major categories, which accounted for 68.0% of the total variance. The results from the spatial autocorrelation analysis showed significant spatial clusters of the cancer categories. Based on the overall consistency of results between this study and those of previous research, this study further identified the high-risk locations and some specific risk factors for major cancer types among Taiwanese women.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24865397 PMCID: PMC4078537 DOI: 10.3390/ijerph110605613
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Secular trends in age-standardized mortality rates of lung, liver, colorectal, breast, and cervix uteri cancers for females in Taiwan, 1986–2009.
Results from the principal component analysis for female cancer types.
| Cancer types | PC1 | PC2 | PC3 | PC4 | PC5 | PC6 | PC7 |
|---|---|---|---|---|---|---|---|
| Bone | 0.24 | 0.07 | −0.14 | 0.14 | −0.09 | −0.12 |
|
| Bladder |
| −0.03 | 0.06 | 0.00 | 0.04 | −0.01 | 0.04 |
| Brain | 0.04 | 0.42 | 0.35 | −0.22 | 0.32 | −0.27 | 0.12 |
| Colon | 0.09 | −0.12 |
| 0.02 | −0.13 | 0.00 | 0.01 |
| Rectum | 0.01 | −0.10 | 0.33 |
| 0.09 | 0.19 | 0.11 |
| Esophagus | −0.08 |
| −0.06 | 0.37 | 0.27 | 0.01 | 0.11 |
| Intestine | 0.05 | 0.10 | 0.00 |
| 0.05 | −0.16 | −0.05 |
| Kidney |
| −0.01 | 0.11 | 0.02 | −0.05 | 0.06 | 0.06 |
| Liver | 0.33 | 0.16 | −0.16 | −0.21 | 0.44 | 0.32 | −0.01 |
| Gallbladder | −0.06 | −0.11 | 0.24 | −0.09 | −0.30 | 0.26 | 0.35 |
| CRRJA a | 0.08 | −0.15 |
| 0.34 | −0.06 | 0.10 | 0.06 |
| Larynx | 0.07 |
| −0.03 | −0.12 | −0.24 | −0.07 | −0.13 |
| Nasopharynx | 0.02 |
| −0.12 | −0.22 | 0.19 | −0.05 | −0.05 |
| Oral cavity | 0.01 |
| −0.19 | 0.38 | 0.04 | −0.07 | −0.08 |
| Pancreas | −0.09 | −0.26 | 0.34 | −0.14 | 0.12 | 0.21 | 0.54 |
| Stomach | −0.03 | 0.44 | −0.28 | −0.01 | 0.58 | 0.12 | 0.20 |
| Skin(non-melanoma) |
| −0.03 | −0.12 | 0.09 | −0.07 | −0.14 | 0.02 |
| Lung |
| 0.11 | 0.13 | −0.05 | 0.17 | 0.24 | 0.04 |
| Breast | −0.03 | −0.05 | 0.46 | −0.07 | 0.17 |
| −0.09 |
| Cervical | 0.00 | −0.05 | 0.06 | 0.20 |
| −0.07 | −0.14 |
| Ovarian | 0.09 | −0.10 | −0.04 | 0.03 | −0.08 |
| 0.08 |
| Eigenvalue | 3.56 | 3.37 | 2.17 | 1.68 | 1.36 | 1.14 | 1.00 |
| % Total variance | 16.95 | 16.04 | 10.31 | 8.01 | 6.46 | 5.43 | 4.78 |
| Cumulative % variance | 16.95 | 33.00 | 43.31 | 51.33 | 57.78 | 63.22 | 68.00 b |
Notes: (1) a CRRJA indicates colon, rectum, rectosigmoid junction and anus cancer. (2) b Total cumulative variance. (3) The PC loading whose absolute value is greater than 0.60 of the total variance were in bold italic.
Given the appropriate name of each cancer category.
| Categories | Category name | Cancers types |
|---|---|---|
| 1 | Urinary system | Bladder, kidney, skin (non-melanoma), lung |
| 2 | Head & neck | Esophagus, larynx, nasopharynx, oral cavity |
| 3 | Colorectal * | Colon, CRRJA |
| 4 | Bowel | Rectum, intestine |
| 5 | Cervical | Cervical |
| 6 | Female sexual organs | Breast, ovarian |
| 7 | Bone | Bone |
Note: * Colorectal cancer includes malignant tumors of the colon and/or the rectum.
Global Moran’s statistics of each principal component.
| Categories | Category Name | Moran’s
| |
|---|---|---|---|
| 1 | Urinary system | 0.401 * | 0.001 |
| 2 | Head & neck | 0.519 * | 0.001 |
| 3 | Colorectal * | 0.270 * | 0.001 |
| 4 | Bowel | 0.095 * | 0.004 |
| 5 | Cervical | 0.208 * | 0.001 |
| 6 | Female sexual rgans | 0.269 * | 0.001 |
| 7 | Bone | 0.063 * | 0.026 |
Note: * p < 0.05.
Figure 2The locations of statistically significant hot spots and cold spots of major female cancer categories.
Summary of characteristic difference between the geographic hot and cold spots in seven major cancer categories.
| Variables | Urinary system | Head & Neck | Colorectal | Bowel | Cervical | Female sexual organ | Bone | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hot | Cold | Hot | Cold | Hot | Cold | Hot | Cold | Hot | Cold | Hot | Cold | Hot | Cold | |
|
| ||||||||||||||
| Pop. Density (people/ha) | 7.6 | 13.5 | 0.8 | 7.1 | 75.8 *** | 1.5 | 2.3 | 1.1 | 17.2 | 8.1 | 118.7 *** | 3.2 | 5.6 | 1.0 |
| Prop. Female (%) | 48.2 | 47.2 | 45.7 | 47.0 | 49.0 *** | 45.8 | 46.1 | 45.7 | 46.4 | 47.4 | 49.8 *** | 46.0 | 46.6 | 45.8 |
| Prop. Aborigines (%) | 0.01 | 0.25 | 1.07 *** | 0.05 | 0.14 | 0.89 | 0.76 | 0.51 | 0.51 * | 0.13 | 0.16 | 0.30 | 0.37 | 0.67 |
| Prop. F. 35~45years (%) | 14.5 | 15.3 | 14.3 | 14.6 | 17.2 *** | 13.8 | 14.1 | 14.1 | 14.9 | 14.7 | 17.9 *** | 13.8 | 14.6 | 14.2 |
| Prop. F. 50~70years (%) | 20.3 ** | 17.4 | 18.3 | 19.6 | 16.6 | 18.5 | 19.6 | 17.7 | 17.0 | 18.9 | 16.9 | 19.3 | 17.6 | 20.5 |
|
| ||||||||||||||
| BQC (per 105 persons) | 14.06 | 15.29 | 34.48 *** | 16.04 | 12.26 | 28.52 | 30.08 | 24.33 | 24.52 * | 18.35 | 11.40 | 18.60 | 13.52 | 23.41 |
| CS (per 105 persons) | 34.83 | 37.51 | 42.88 *** | 36.42 | 36.33 | 42.31 | 41.45 | 36.00 | 39.43 | 37.13 | 38.08 | 38.13 | 37.12 | 41.06 |
|
| ||||||||||||||
| As (mg/L) | 7.7 *** | 4.5 | 3.3 | 6.0 | 4.0 | 4.7 | 2.7 | 7.9 | 3.3 | 6.4 | 4.2 | 5.7 | 2.6 | 3.2 |
| Cd (mg/L) | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.1 | 0.2 | 0.1 | 0.04 | 0.1 | 0.2 | 0.1 | 0.05 | 0.1 |
| Cr (mg/L) | 0.2 | 1.5 | 0.4 | 0.6 | 3.3 * | 0.6 | 0.5 | 0.1 | 0.3 | 1.2 | 1.8 | 0.8 | 1.1 * | 0.1 |
| Cu (mg/L) | 4.0 | 10.0 | 7.9 | 5.7 | 16.1 | 8.4 | 12.5 | 3.5 | 7.0 | 5.7 | 13.6 ** | 5.5 | 9.2 | 6.3 |
| Hg (mg/L) | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 * | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 |
| Ni (mg/L) | 1.8 | 2.8 | 4.0 *** | 1.9 | 4.1 | 3.9 | 3.5 | 2.1 | 1.7 | 3.3 | 3.2 | 2.7 | 1.2 | 3.1 |
| Pb (mg/L) | 6.3 | 10.1 | 7.1 | 7.7 | 10.8 | 8.9 | 10.8 | 5.0 | 9.6 * | 6.8 | 10.6 * | 7.9 | 12.8 ** | 7.4 |
| Zn (mg/L) | 8.8 | 15.2 | 9.9 | 10.0 | 20.8 | 10.3 | 10.9 | 6.1 | 8.8 | 11.0 | 16.6 | 10.0 | 10.1 | 8.3 |
Notes: (1) Urinary system cancers include bladder, kidney, skin(non-melanoma), and lung cancers; head & neck cancers include esophagus, larynx, nasopharynx, and oral cavity cancers; colorectal cancers include malignant tumors of the colon and/or the rectum; bowel cancers include rectum and intestine cancers; female sexual organs cancers include breast and ovarian cancers. (2) The number of townships is shown in parentheses. (3) Abbreviations: BQC, betel quid chewing; CS, cigarette smoking; Hot, hot spots; Cold, cold spots. (4) The average value of a given variable in hot spots is significantly larger than that in cold spots, and the significance is determined by a Student’s t-test: * p < 0.05, ** p < 0.01, *** p < 0.001.